ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "work"

  • Abstract Number: 1941 • ACR Convergence 2024

    No Show QI at Hoxworth Rheumatology Clinic: Evaluating the Impact of Live Telephone Calls Combined with Automated Reminders

    Nicola Jackson1, kim Nguyen2, Tien Nguyen3, Meg James3 and Avis Ware4, 1University of Cincinnati, Blue Ash, 2Trihealth Hospital, Cincinnati, 3University of Cincinnati, Cincinnati, 4University of Cincinnati, Cincinnati, OH

    Background/Purpose:  Patient no-show and cancellation rates are long-standing problems in the healthcare system, affecting patient outcomes, revenue, system efficiency, and resource utilization. At the Hoxworth…
  • Abstract Number: 2322 • ACR Convergence 2024

    Predictors of Work Impairment and Absence Amongst People with Psoriatic Arthritis (PsA) – Evidence from the British Society for Rheumatology PsA Register (BSR-PsA)

    Lili Xu1, Gareth Jones1, Ovidiu Rotariu1, Philip S. Helliwell2, Stefan Siebert3, Rosemary Hollick1 and Gary Macfarlane1, 1University of Aberdeen, Aberdeen, United Kingdom, 2Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK, Leeds, United Kingdom, 3School of Infection and Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom

    Background/Purpose: People with PsA often report that their condition affects their ability to work. Poor work outcomes, such as work impairment, absence or leaving work,…
  • Abstract Number: 2416 • ACR Convergence 2024

    The Impact of Active Lupus Nephritis on Work Productivity in Patients from a Latin American Lupus Cohort

    Romina Nieto1, Rosana Quintana2, Diana Carolina Fernández Ávila3, Rosa Serrano Morales4, Guillermina Harvey5, Lucia Hernandez6, Karen Roberts7, Luis Catoggio8, Gisela Subils9, Carla Gobbi10, Bordón Florencia Juliana11, Pablo David Ibáñez Peña12, Leonel Ariel Berbotto13, María C. Bertolaccini14, Diego O. Riseni15, María De Los Ángeles Gargiulo16, Cecilia Pisoni17, Joaquín Martínez Serventi18, Emilio Buschiazzo19, Vitalina De Souza Barbosa20, ODIRLEI MONTICIELO21, Carolina Albanez de A. Da C. Andrade22, Francinne Machado Ribeiro23, Eloisa Bonfa24, Eduardo Borba24, Emília Sato25, Alexis Bondi Peralta26, Silvana Donoso27, Gustavo Aroca Martínez28, Hellen Medina28, Alex Echeverri29, Sebastián Molina-Rios30, Manuela Rubio31, Rafael López32, Mario Moreno33, Olga Lidia Vera Lastra34, Mario Pérez Cristóbal35, Carlos Núñez-Álvarez36, luis M Amezcua Guerra37, Ignacio García-Valladares38, Carlos Abud Mendoza39, Dionicio Galarza-Delgado40, Marcos Vázquez41, Astrid Paats42, Jorge N. Cieza Calderón43, Ana Mabel Quiroz Alva44, Roberto Muñoz Louis45, Carina Pizzarossa46, Adriana Carlomagno47 RV Gamboa-Cardenas48, Graciela Alarcon49, Urbano Sbarigia50, Federico Zazzetti51, Ashley Orillion52, Guillermo Pons-Estel1 and Bernardo Pons-Estel1, 1Centro Regional de Enfermedades Autoinmunes y Reumaticas. GO-CREAR, Rosario, Santa Fe, Argentina, 2Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina, 3Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina, Rosario, Argentina, 4Sanatorio Parque. Centro de Enfermedades Autoinmunes y Reumaticas del Grupo Oroao., Rosario, Argentina, 5Escuela de Estadística, Facultad de Ciencias Económicas y Estadística, Universidad Nacional de Rosario, Rosario, Argentina, Rosario, Argentina, 6Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), ROSARIO, Santa Fe, Argentina, 7Sección Reumatología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 8Sección Reumatología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina;, Buenos Aires, Argentina, 9Hospital Italiano de Córdoba, Córdoba, Argentina, Córdoba, Argentina, 10Hospital Córdoba, Ciudad de Córdoba, Argentina, Córdoba, Argentina, 11Hospital Privado Universitario de Córdoba, Córdoba, Argentina, 12Hospital HIGA San Martín, La Plata, Argentina, La Plata, Argentina, 13Unidad de Enfermedades Autoinmunes, Hospital Escuela Eva Perón, Granadero Baigorria, Argentina, Granadero Baigorria, Argentina, 14Hospital Padilla, Tucumán, Argentina, Tucumán, Argentina, 15Hospital General de Agudos J.M. Ramos Mejía, Buenos Aires, Argentina, Buenos Aires, Argentina, 16Instituto de Investigaciones Médicas Alfredo Lanari, Buenos Aires, Argentina, Buenos Aires, Argentina, 17CEMIC, Buenos Aires, Argentina, 18Hospital General de Agudos Dr. Juan A. Fernández, Buenos Aires, Argentina, CABA, Argentina, 19Hospital Señor del Milagro, Salta, Argentina, Salta, Argentina, 20Hospital das Clínicas, Universidade Federal de Goias, Goias, Brazil, Goiânia, Brazil, 21HOSPITAL DE CLINICAS DE PORTO ALEGRE, PORTO ALEGRE, Rio Grande do Sul, Brazil, 22Universidade Federal de Pernambuco, Pernambuco, Brazil, Pernambuco, Brazil, 23Hospital Universitario Pedro Ernesto, UERJ, Rio De Janeiro, Brazil, Rio de Janeiro, Brazil, 24Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, São Paulo, SP, Brazil, 25Universidade Federal de Sao Paulo, São Paulo, SP, Brazil, 26Hospital del Salvador, Santiago, Chile, 27Clinical Laboratory Hospital Regional Libertador Bernardo O'Higgins, Rancagua, Chile, Rancagua, Chile, 28Universidad Simón Bolivar, Barranquilla, Colombia, Barranquilla, Colombia, 29Fundación Valle del Lili, Unidad de Reumatología, Colombia, Reumatología, Colombia, 30Facultad de Medicina, Universidad Nacional de Colombia. Hospital Universitario Nacional, Bogotá, Colombia, 31Centro de Estudios de Reumatología & Dermatología SAS, Bogotá, Colombia, 32Servicio de Reumatología. Hospital Luís Vernaza, Guayaquil, Ecuador, Guayaquil, Ecuador, 33Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador, Guayaquil, Ecuador, 34División de Investigación en Salud, Hospital de Especialidades Dr. Antonio Fraga Mouret, CMN La Raza, CDMX, Mexico, 35Centro Médico Nacional Siglo XXI, CDMX, Mexico, IMMS, Mexico, 36Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, CDMX, Mexico, Mexico, Mexico, 37Department of Immunology, Instituto Nacional de Cardiología Ignacio Chávez., México, Mexico, 38Depto. de Inmunología y Reumatología, Hospital General de Occidente y Universidad de Guadalajara, Guadalajara, Mexico, Guadalajara, Mexico, 39Hospital Central Dr. Ignacio Morones Prieto, SLP, México, SLP, Mexico, 40UANL Hospital Universitario, Monterrey, Nuevo León, Mexico, 41Hospital de Clínicas I, Asunción, Paraguay, Asuncion del Paraguay, Paraguay, 42Hospital de Clínicas I, Asunción, Paraguay, 43Hospital Nacional Edgardo Rebagliatti Martins, Lima, Perú, Lima, Peru, 44Hospital Cayetano Heredia, Lima, Perú, Lima, Peru, 45Hospital Docente Padre Billini, Santo Domingo, República Dominicana, Santo Domingo, Dominican Republic, 46Clínica Médica C, Hospital de Clínicas, UDELAR, Montevideo, Uruguay, 47Grupo de Investigación de EAIS y Reumatológicas, Montevideo, Uruguay, 48Universidad Científica del Sur, Lima, Lima, Peru, 49The University of Alabama at Birmingham, Birmingham, AL, 50Johnson & Johnson Innovative Medicine, Brussels, Belgium, 51Johnson & Johnson Innovative Medicine, Horsham, PA, PA, 52Johnson & Johnson Innovative Medicine, Spring House, PA

    Background/Purpose: The Latin American Group for the Study of Lupus (GLADEL) 2.0 is an observational prevalent and incident cohort of patients with systemic lupus erythematosus…
  • Abstract Number: 0350 • ACR Convergence 2024

    Piloting an Adaptation of the Making It Work Program for Systemic Sclerosis: Promising Effects on Job Related Self-efficacy and Risk of Work Disability

    Janet Poole1, Kristine Carandang2, Mary Thelander Hill1, Jessica Salazar1, Anna Koch3, Timothy Dionne1 and Diane Lacaille4, 1University of New Mexico, Albuquerque, NM, 2Young Patients' Autoimmune Research & Empowerment Alliance, San Diego, CA, 3Comfy Couch Counseling LLC, Albuquerque, NM, 4Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Although work disability presents a substantial burden for people with systemic sclerosis (SS), there are no tailored programs that aim to support their employment.…
  • Abstract Number: 0561 • ACR Convergence 2024

    Axial Spondyloarthritis Patients with Comorbid Fibromyalgia Feel Worse, Work Less and More Often Try Multiple Biological DMARDs − Results from a Population-Based Cohort

    Annie Brink1, Elisabeth Mogard2, Elisabet Lindqvist2, Jonas Sagard2, Johan Karlsson Wallman1 and Tor Olofsson2, 1Lund University, Department of Clinical Sciences Lund, Section of Rheumatology and Skåne University Hospital, Lund, Sweden, Lund, Skane Lan, Sweden, 2Lund University, Department of Clinical Sciences Lund, Section of Rheumatology and Skåne University Hospital, Lund, Sweden, Lund, Sweden

    Background/Purpose: A growing arsenal of biologic/targeted synthetic DMARDs often makes inflammation control an attainable target in axial spondyloarthritis (axSpA). Yet, many patients keep suffering from…
  • Abstract Number: 0587 • ACR Convergence 2024

    Achieving Stringent Disease Control Criteria Was Associated with Greater Work Productivity Improvements in Patients with Active Psoriatic Arthritis: Results from Two Phase 3 Studies of Bimekizumab

    William Tillett1, Dafna Gladman2, Laure Gossec3, Jason Eells4, Patrick Healy5, Barbara Ink4, Nikos Lyris4 and Jessica A Walsh6, 1Royal National Hospital of Rheumatic Diseases; Department of Life Sciences, Centre for Therapeutic Innovation, University of Bath, Bath, United Kingdom, 2University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 3Sorbonne Université, Paris, France, 4UCB Pharma, Slough, United Kingdom, 5UCB Pharma, Morrisville, NC, 6Division of Rheumatology, Salt Lake City Veterans Affairs Health and University of Utah Health, Salt Lake City, UT

    Background/Purpose: Psoriatic arthritis (PsA) negatively impacts patients’ physical health and functional ability, which can contribute to reduced work productivity.1,2 We examined the association between achieving…
  • Abstract Number: 1074 • ACR Convergence 2024

    Bending the Curve on Inbox Bloat: A Patient Portal Project to Mature-the-Message via Nurse Triage to Reduce Provider Inbox Time

    Christie Bartels1, Sancia Ferguson2, Carmen Campbell1, Lori Zemlicka3, Amanda Weber3, Andrew Holt1 and Elizabeth R. Trowbridge4, 1University of Wisconsin School of Medicine and Public Health, Madison, WI, 2University of Wisconsin, Madison, Madison, WI, 3UW Health Rheumatology, Madison, WI, 4Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI

    Background/Purpose: Clinical demands have grown, in part, from rising use of patient portals, while traditional clinic nurse triage has focused on phone-based care. We sought…
  • Abstract Number: 1254 • ACR Convergence 2024

    The Impact of Eosinophilic Granulomatosis with Polyangiitis on the Health-Related Quality of Life of Patients and Their Ability to Work: Evidence from a Real-World Survey in Clinical Practice

    Robert Spiera1, Paul Dolin2, Anat Shavit2, Jennifer Rowell3, Chris Edmonds4, Josefine Persson5, Danuta Kielar6, Daniel Mascia7, James Siddall7, Tia Pennant7, Fritha Hennessy7 and Stephanie Y. Chen8, 1Scleroderma, Vasculitis, and Myositis Center, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, 2BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom, 3Market Access and Pricing, AstraZeneca, Cambridge, England, United Kingdom, 4Market Access and Pricing, AstraZeneca, Gaithersburg, MD, 5Market Access and Pricing, AstraZeneca, Gothenburg, Sweden, 6Biopharmaceuticals Medicine, AstraZeneca, Cambridge, United Kingdom, 7Adelphi Real World, Bollington, United Kingdom, 8BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD

    Background/Purpose: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare anti-neutrophil cytoplasmic antibody-associated vasculitis that confers significant disease burden. This real-world study described the impact of…
  • Abstract Number: 1500 • ACR Convergence 2024

    Work-Related Disability and Function in Systemic Lupus Erythematosus (SLE): Outcomes of an Exploratory Study from Different Canadian Centres

    Behdin Nowrouzi-Kia1, J. Antonio Avina-Zubieta2, Mary Fox3, William Shaw4, Maggie Ho5, Qixuan Li5, Catherine Ivory6, Paul Fortin7, Stephanie Keeling8, Jennifer Reynolds9, Derek Haaland10, Janet Pope11, Lily Lim12, Patti Katz13, Murray Urowitz14, Laura Patricia Whittall Garcia5, Dafna Gladman15 and Zahi Touma1, 1University of Toronto, Toronto, ON, Canada, 2Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada, 3York University, Toronto, ON, Canada, 4University of Connecticut, School of Medicine, Farmington, CT, 5University Health Network, Toronto, ON, Canada, 6The Ottawa Hospital, Ottawa, ON, Canada, 7Centre ARThrite - CHU de Québec - Université Laval, Quebec, QC, Canada, 8University of Alberta, Edmonton, AB, Canada, 9UBC, North Vancouver, BC, Canada, 10The Waterside Clinic, Oro Medonte, ON, Canada, 11University of Western Ontario, London, ON, Canada, 12University of Manitoba, Winnipeg, MB, Canada, 13UCSF, San Rafael, CA, 14Self employed, Toronto, ON, Canada, 15University of Toronto, Toronto Western Hospital, Toronto, ON, Canada

    Background/Purpose: Systemic lupus erythematosus (SLE) has a significant and long-lasting impact on work outcomes, is a source of long-lasting work disability, and presents challenges with…
  • Abstract Number: 1741 • ACR Convergence 2024

    Implementing Strengths-Based, Positive Approaches Within Rheumatology Fellowship Training: A Realist Evaluation of Appreciative Inquiry-Based Interventions

    Alick Feng1, Manish Suneja1 and Bharat Kumar2, 1UNVERSITY OF IOWA HOSPITALS AND CLINICS, Iowa City, IA, 2University of Iowa Hospitals and Clinics, Iowa City, IA

    Background/Purpose: Appreciative Inquiry (AIn) is a strengths-based organizational framework to promote engagement and change.  It has shown promise in graduate medical education (GME) settings but…
  • Abstract Number: 1257 • ACR Convergence 2023

    The Psychological Experience of Work for People with Inflammatory Arthritis (IA)

    Joan Westreich1, Adena Batterman1, Anna Balakrishnan1, Roberta Horton1, Minerva Nong1, Vivian Bykerk2 and Theodore Fields1, 1Hospital for Special Surgery, New York, NY, 2Department of Rheumatology, Hospital for Special Surgery, New York, NY

    Background/Purpose: A large body of research reports that people with inflammatory arthritis (IA) are at increased risk for work disability, which profoundly affects all aspects…
  • Abstract Number: 1407 • ACR Convergence 2023

    Defining Thresholds of Presenteeism Measures for Unacceptable Work Participation in axSpA

    Dafne Capelusnik1, Sofia Ramiro2, Elena Nikiphorou3, Walter P. Maksymowych4, Marina Nighat Magrey5, Helena Marzo-Ortega6 and Annelies Boonen7, 1Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 2Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3King's College London, London, United Kingdom, 4University of Alberta, Edmonton, AB, Canada, 5Case Western Reserve University, University Hospitals, Cleveland, OH, 6NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 7Care and Public Health Research Institute (Caphri), Maastricht University, Maastricht, Netherlands

    Background/Purpose: Presenteeism is associated with lower work satisfaction and future sick leave in axial spondyloarthritis (axSpA). It is generally assessed as a continuous variable; however,…
  • Abstract Number: 1415 • ACR Convergence 2023

    Bimekizumab Treatment Impact on Work Productivity in Biologic DMARD‑Naïve and TNFi-IR Patients with Active Psoriatic Arthritis: Results up to 1 Year from Two Phase 3 Studies

    Philip J. Mease1, Dafna Gladman2, Laure Gossec3, Peter Nash4, Barbara Ink5, Jason Coarse6, Nikos Lyris5, Damon Willems7 and William R Tillett8, 1Swedish Medical Center/Providence St. Joseph Health and University of Washington School of Medicine, Seattle, WA, 2Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, Department of Medicine, University of Toronto, Toronto, ON, Canada, 3Sorbonne Université and Pitié Salpêtrière Hospital, Paris, France, 4School of Medicine, Griffith University, Brisbane, Australia, 5UCB Pharma, Slough, United Kingdom, 6UCB Pharma, Morrisville, NC, 7UCB Pharma, Brussels, Belgium, 8Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom

    Background/Purpose: PsA impacts the physical health and functional ability of patients (pts),which can contribute to reduced work productivity.1 Bimekizumab (BKZ) is a monoclonal IgG1 antibody…
  • Abstract Number: 1416 • ACR Convergence 2023

    Improvement of Work Absenteeism Following Start of Methotrexate Monotherapy in Newly-Diagnosed Psoriatic Arthritis

    Ulf Lindström1, Daniela Di Giuseppe2, Sofia Exarchou3, Gerd-Marie Alenius4, Tor Olofsson5, Eva Klingberg1, Lennart Jacobsson6, Johan Askling2 and Johan Karlsson Wallman5, 1University of Gothenburg, Gothenburg, Sweden, 2Karolinska Institutet, Stockholm, Sweden, 3Lund University, Åkarp, Sweden, 4Umeå University, Umeå, Sweden, 5Lund University and Skåne University Hospital, Lund, Sweden, 6University of Gothenburg, Malmö, Sweden

    Background/Purpose: In many countries, methotrexate (MTX) monotherapy is the first-line disease-modifying anti-rheumatic drug (DMARD) therapy for psoriatic arthritis (PsA), despite that its efficacy in PsA…
  • Abstract Number: 1973 • ACR Convergence 2023

    Work-related Impact in Young Patients with Chronic Back Pain Awaiting a Magnetic Resonance Imaging

    Diego Benavent1, Mar Tapia2, Daniel Bernabeu2, Victor muley2, Chamaida Plasencia-Rodríguez3, Alejandro Balsa3 and Victoria Navarro-Compán4, 1Hospital la Paz, Madrid, Spain, 2Radiology Department, Hospital La Paz, Madrid, Spain, 3Hospital Universitario La Paz, Madrid, Spain, 4Department of Rheumatology, La Paz University Hospital, IdiPaz, Madrid, Spain

    Background/Purpose: Chronic back pain (CBP) is one of the major causes for medical consultation among young people. Given the limited sources, it is relevant knowing…
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology